Class-Action Status Upheld (Vioxx heart problem) in Merck Case

Class-Action Status Upheld (Vioxx heart problem) in Merck Case

Class-Action Status Upheld in Merck Case
Street.Com - A lawyer said a New Jersey appeals court granted class-action status for certain plaintiffs in their claims against Merck ( MRK :NYSE - news - research - Cramer's Take ) over its arthritis drug Vioxx. Chris Seeger, the lead attorney for a union
Source: www.thestreet.com

Chronology of events surrounding Vioxx and other painkillers
Courier-Post - December 1998: Food and Drug Administration approves Pfizer Inc.'s Celebrex, the first Cox-2 inhibitor, to treat arthritis. Cox-2 drugs, part of the nonsteroidal anti-inflammatory (NSAID) drug class, inhibit the Cox-2 enzyme, which promotes
Source: www.courierpostonline.com